Profile

Cover photo
The Cheap Investor
53 followers|18,661 views
AboutPostsPhotosVideos

Stream

The Cheap Investor

Shared publicly  - 
 
Chart of Day: The Biotech M&A Boom Continues - In early April 2016, we noted, “Biotech may have had a rough start to the year, lagging many other sectors. But don’t count it out just yet.  In fact, buy all you can.  The same strong catalysts and fundamentals are still firmly in place. Even though the first quarter of 2016 showed slower M&A activity, I can assure you the trend is far from over.” As it turns out, we were absolutely right. Just this week, Pfizer agreed to buy Medivation (MDVN)...
In early April 2016, we noted, “Biotech may have had a rough start to the year, lagging many other sectors. But don’t count it out just yet. In fact, buy
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Why Are Billionaires Piling Into This 4000% Growth Industry?
It’s my favorite time of year. Yes, I live in Scottsdale, Arizona. It’s August. The heat is unbearable. The town grounds to a halt when it passed 110 degre
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Fair Warning: Longest Losing Streak in 37 years - U.S. economic growth is “pretty damn good.” That’s what billionaire investor Warren Buffett said in an interview this week. While he admitted GDP of less than 2% doesn’t match the quicker pace of decades past, he still believes the economy is just fine. When it comes to productivity, he noted: “If you don’t improve productivity, you don’t go anyplace. And fortunately, we have a system—we’re in the early innings of it, but we have a system wh...
U.S. economic growth is “pretty damn good.” That’s what billionaire investor Warren Buffett said in an interview this week. While he admitted GDP of less t
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Market Analyst: What’s Really Behind the July Unemployment Numbers
Just last week, we got what some called a “stellar jobs report.” The U.S. announced employers added 255,000 jobs in July 2016, easily beating analyst expec
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Biotech: Why we never feared the Bubble - It was one of the most powerful -- most lucrative – moves of the last six years. Between January 2011 and July 2015, the NASDAQ Biotech Index (IBB) moved from a low of 95 to a high of 401, returning gains of 322% as compared to S&P 500 returns of just 67%. Then it all came crashing down. A year later, the IBB plunged from that July 2015 high of 401 to 240.  As the IBB dropped, we found many biotech stocks had become severely undervalued, trading at ...
It was one of the most powerful -- most lucrative – moves of the last six years. Between January 2011 and July 2015, the NASDAQ Biotech Index (IBB) moved f
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
U.S. Growth: The Weakest Recovery in 67 Years - Second quarter 2016 grew at an annual rate of just 1.2% -- well below expectations of 2.6% -- thanks to continued weakness in business investment. That alone should give the Federal Reserve reason to rethink raising rates anytime soon. Even after the U.S. has given businesses a great deal of tools to drive such investment, including borrowing rates at near-zero interest rate and higher credit availability, businesses are not spending as robust...
Second quarter 2016 grew at an annual rate of just 1.2% -- well below expectations of 2.6% -- thanks to continued weakness in business investment. That alo
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Hillary Clinton 2016: Where she stands on taxes - It’s looking like a nose-to-nose fight to the finish. At the moment, 41% of Americans are in favor of Hillary Clinton.  Another 37% backs Donald Trump.  About 10% are in favor of Libertarian candidate Gary Johnson, and another 4% in favor of Green Party candidate Jill Stein. But it’s the main contenders that are generating quite a firestorm about how to turn around our lackluster economy. It’s surely coming down to the wire.  Last Wednesday ...
It’s looking like a nose-to-nose fight to the finish. At the moment, 41% of Americans are in favor of Hillary Clinton. Another 37% backs Donald Trump. Ab
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Chart of Day: Dow 20,000? - Dow Jones 36,000 may remain a pipe dream.  But analyst expectations for 20,000 could soon be reality.  In fact, as of last week, the consensus one-year estimate on Wall Street is now 20,003.93, up from an earlier projection of 19,914.  And it’s not as farfetched as you’d think especially in such a low interest rate environment with no real rate hike threats on the horizon. Despite true unemployment numbers, poor GDP, negative wage growth, weak productivity, slowi...
Dow Jones 36,000 may remain a pipe dream. But analyst expectations for 20,000 could soon be reality. In fact, as of last week, the consensus one-year est
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Chart of Day: Monster Worldwide (MWW) Acquired - In the March 2016 issue of The Cheap Investor, we recommended Monster Worldwide (MWW) at just $2.94 a share. At the time, the company had a strong balance sheet with $168 million in cash and a book value of $5.39 a share.  Even with a large debt of $199 million, we were still attracted to the stock. As of this week, shares are up to $3.50 on news that Randstad Holding NV agreed to buy the company for $429 million – or $3.40 share, a 23% premi...
In the March 2016 issue of The Cheap Investor, we recommended Monster Worldwide (MWW) at just $2.94 a share. At the time, the company had a strong balance
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Chart of Day: Rigel Pharmaceuticals (RIGL) runs 64% - After a brutal sell-off in the biotech sector, we found a great deal of severely undervalued names trading at extremely low prices.  It’s why we recommended Rigel Pharmaceuticals (RIGL) at just $1.95 a share in the April 2016 issue of The Cheap Investor.  We liked this stock in particular because it was undervalued with a substantial cash position of $126 million. At its current burn rate, that cash should last the Company for several ye...
After a brutal sell-off in the biotech sector, we found a great deal of severely undervalued names trading at extremely low prices. It’s why we recommende
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
Chart of Day: Adverum Biotechnologies (ADVM) begins to run - We’ve pounded the table for biotech stocks for months. All as the pundits noted the sector run was over.  But as it turned out, we were right, as former bears turn bullish, jumping into the sector’s hottest names. Earnings for many sector giants have been red hot.  Undervalued names are bouncing back.  Mergers are in full swing after a record-breaking string of activity in 2015.  Relypsa for example is being acquired as part of a ...
We’ve pounded the table for biotech stocks for months. All as the pundits noted the sector run was over. But as it turned out, we were right, as former be
1
Add a comment...

The Cheap Investor

Shared publicly  - 
 
U.S. Election 2016: Hillary Clinton’s Vision - The race for the Oval office is on fire. Both sides of the aisle are at each other’s throat, demanding change. Just days after Donald Trump clinched the Republican nomination for the U.S. presidential ticket the Democratic National Committee commenced its nomination of Hillary Clinton. All as the nail biting race for the White House heats up. At the moment, 46% of U.S. voters say they’ll vote for Trump in November.  About 45% say they want Hill...
The race for the Oval office is on fire. Both sides of the aisle are at each other’s throat, demanding change. Just days after Donald Trump clinched the Re
1
Add a comment...
People
Have them in circles
53 people
Lisa Dixson's profile photo
Cassidy Samantha's profile photo
Buy to Let Bradford's profile photo
D M's profile photo
Kedai Komoditi's profile photo
Gary Hess's profile photo
freeborn okiemute's profile photo
Architect Akram's profile photo
Sam Eder's profile photo
Contact Information
Contact info
Phone
(877) 306-4256
Email
Story
Tagline
Founded in 1981 by Bill Mathews, The Cheap Investor newsletter is all about discovering quality stocks trading for less than $5 per share.
Introduction
Since 1981, The CHEAP Investor newsletter has been an intelligent and straightforward guide to choosing low-price quality stocks and has helped thousands of investors make profitable investment decisions. Subscribers get the information that they need to purchase stocks with great profit potential at the lowest price. The CHEAP Investor was rated the #1 Best Performing Market Letter for the five-year period ending November 2006, by Select Information Exchange and one of the four best small stock advisories in America by the League of American Investors.


Bill Mathews
Recognized as one of the foremost authorities on investing in small-cap stocks, Bill Mathews has been a frequent guest on radio and television shows nationwide such as CNBC. He has been interviewed by major newspapers and magazines including the Wall Street Journal, Business Week, Barrons and the Chicago Tribune. Bill Mathews is the author of the book "Making Big Money in Small Stocks" which describes specific techniques for analyzing stocks easily and profitably as well as determining what might affect a stock's profit potential. Mr. Mathews also taught securities analysis for the MBA program at the Keller Graduate School of Management, and spent 15 years teaching business and investment courses at Triton College.